The evening of May 10, 2022, the Friends of Cancer Research held their 25th Anniversary Dinner Celebration at the Four Seasons Hotel in Washington, DC. As part of the event, they recognized 25 scientific and advocacy leaders who, through their work and partnership, have been instrumental over the course of the last 25 years in making significant advancements for patients.
Roy S. Herbst, MD, PhD, was recognized at the event for his contributions in lung cancer as one of the foremost leaders in lung cancer treatment and research. He is an original architect and principal investigator of Lung-MAP, a first-of-its-kind clinical trial that originated from one of the Friends of Cancer Research Annual Meetings and has reshaped how clinical trials are conducted. Dr. Herbst is Deputy Director for Clinical Affairs, Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology, and Chief of Medical Oncology at Yale Cancer Center and Smilow Cancer Hospital, and Assistant Dean for Translational Research at Yale School of Medicine.
Some of his fellow honorees included President Joe Biden, Dr. Peter Marks, Director of the Center for Biologics Evaluation & Research at the FDA, Dr. Margaret Hamburg, Interim Vice President of Global Biological Policy and Programs, NTI, and Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease (NIAID).
“I am honored to be among those recognized tonight, and to have played a role in the amazing level of success that Friends has achieved for patients over the last 25 years,” said Dr. Herbst. Friends of Cancer Research has spent decades at the forefront of cancer research, uniting scientists, experts, advocates, and patients to improve resources, policy, and treatments for patients.
